Integrated in silico tools for exploiting the natural products' bioactivity

Planta Medica

Volumn 72, Issue 8, 2006, Pages 671-678

  Rollinger, Judith Maria ^a   Langer, T ^a,b   Stuppner, H ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Software Engineering and Consulting   (Austria)

Author keywords

Drug discovery; In combo approach; Natural products; Neural network; Pharmacophore modelling; Virtual screening

Indexed keywords

NATURAL PRODUCT;

COMPUTER ANALYSIS; COMPUTER MODEL; DATA BASE; DRUG ACTIVITY; FILTER DESIGN; INFORMATION SYSTEM; INTEGRATED CIRCUIT; LIGAND BINDING; MEDICAL RESEARCH; METABOLITE; MOLECULAR BIOLOGY; PHARMACOPHORE; SCREENING; SHORT SURVEY; SIMULATION; VIRTUAL REALITY;

COMPUTER-AIDED DESIGN; DRUG DESIGN; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

EID: 33746042161     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941506     Document Type: Short Survey

References (40)

1. Schmitz R. Geschichte der Pharmazie.; Vol. 1, Von den Anfängen bis zum Ausgang des Mittelalters Eschborn: Govi-Verlag, 1998: p 3
2. Cragg GM, Newman DJ. Biodiversity: A continuing source of novel drug leads. Pure Appl Chem 2005; 77: 7-24
3. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003; 66: 1022-37
4. Hadacek F. Secondary metabolites as plant traits: current assessment and future perspectives. CRC Crit Rev Plant Sci 2002; 21: 273-322
5. Lahana R. How many leads from HTS? Drug Discov Today 1999; 4: 447-8
6. Gasteiger J, Teckentrup A, Terfloth L, Spycher S. Neural networks as data mining tools in drug design. J Phys Org Chem 2003; 16: 232-45
7. Chapman & Hall/CRC Press LLC. Dictionary of natural products. Available at http://www.chemnetbase.com. Accessed February 2006
8. Xu J, Hagler A. Chemoinformatics and drug discovery. Molecules 2002; 7: 566-600
9. Güner OF. Pharmacophore perception, development, and use in drug design. IUL Biotechnology Series. La Jolla: International University Line, 2000
10. Böhm H-J, Schneider G, Kubinyi H, Mannhold R, Timmerman H. Virtual screening for bioactive molecules.; Vol. 10, In: Mannhold R, Kubinyi H, Timmermann H, editors. Methods and principles in medicinal chemistry New York: Wiley, 2000
11. Abagyan R, Totrov M. High-throughput docking for lead generation. Curr Opin Chem Biol 2001; 5: 375-82
12. Schneider G, Böhm HJ. Virtual screening and fast automated docking methods. Drug Discov Today 2002; 7: 64-70
13. Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H et al. The protein data bank. Nucleic Acids Res 2000; 28: 235-42
14. Wolber G, Langer T. LigandScout: 3D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005; 45: 160-9
15. Inte:Ligand GmbH. Vienna, Austria. LigandScout: 3D pharmacophore modelling tool. Available at http://www.inteligand.com. Accessed February 2006
16. Congreve M, Murray CW, Blundell TL. Structural biology and drug discovery. Drug Discov Today 2005; 10: 895-907
17. Rollinger JM, Hornick A, Langer T, Stuppner H, Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J Med Chem 2004; 47: 6248-54
18. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 2004; 47: 2430-40
19. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 2000; 408: 1008-12
20. Morris GM, Goodsell DS, Huey R, Olson AJ. Distributed automated docking of flexible ligands to proteins: parallel applications of Auto-Dock 2.4. J Comput Aided Mol Des 1996; 10: 293-304
21. Langer T, Krovat EM. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. Curr Opin Drug Discov Dev 2003; 6: 370-6
22. Accelrys Inc., San Diego. CA, USA. Catalyst: programme for modelling, database management, and querying for drug discovery. Available at http://www.accelrys.com. Accessed January 2006
23. Laggner C, Schieferer C, Fiechtner B, Poles G, Hoffmann RD, Glossmann H et al. Feature based pharmacophore models for sigmal receptor, ERG2 and EBP. J Med Chem 2005; 48: 4754-64
24. Zupan J, Gasteiger J. Neural networks in chemistry and drug design, 2nd edition. Weinheim: Wiley-VCH, 1999
25. Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern 1982; 43: 59-69
26. Wagner S, Hofmann A, Siedle B, Terfloth L, Merfort I, Gasteiger J. Development of a structural model for NF-κB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem 2006; 49: 241-52
27. Bernard P, Berton JY, Chrétien JR. Computer-aided molecular selection and design of natural bioactive molecules. Curr Opin Drug Discov Dev 1999; 2: 213-23
28. Kirchmair J, Laggner C, Wolber G, Langer T. Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms. J Chem Inf Model 2005; 45: 422-30
29. Lu A, Liu B, Liu H, Zhou J, Xie G. A traditional Chinese medicine plant-compound database aid its application for searching. Int Electron J Mol Des 2004; 3: 672-83
30. Lei J, Zhou J. A marine natural product database. J Chem Inf Comput Sci 2002; 42: 742-8
31. Rollinger JM, Haupt S, Stuppner H, Langer T. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example. J Chem Inf Comput Sci 2004; 44: 480-8
32. Rollinger JM, Bodensieck A, Seger C, Ellmerer EP, Bauer R, Langer T et al. Discovering COX-inhibiting constituents of Morus root bark: activity-guided versus computer-aided methods. Planta Med 2005; 71: 399-405
33. Development Therapeutics Program NCI/NIH. Open NCI database. Available at http://dtp.nci.nih.gov/webdata.html. Accessed in March 2006
34. Poroikov VV, Filimonov DM, Ihlenfeldt W-D, Gloriozova TA, Lagunin AA, Borodina YV et al. PASS biological activity predictions in the enhanced open NCI database browser. J Chem Inf Comput Sci 2003; 43: 228-36
35. Cherkasov A, Shi Z, Fallahi M, Hammond GL. Successful in silica discovery of novel nonsteroidal ligands for human sex hormone binding globulin. J Med Chem 2005; 48: 3203-13
36. Van de Waterbeemd H. High-throughput and in silico techniques in drug metabolism and pharmacokinetics. Curr Opin Drug Discov Dev 2002; 5: 33-43
37. Bernard P, Scior T, Didier B, Hibert M, Berthon J-Y. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors. Phytochemistry 2001; 58: 865-74
38. 2. Eur J Med Chem 2001; 36: 1-19
39. Rollinger JM, Mock P, Zidorn C, Ellmerer EP, Langer T, Stuppner H. Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus. Curr Drug Discov Technol 2005; 2: 185-93.
40. Corrections: Curr Drug Discov Technol 2006; in press